Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Nektar Therapeutics is a biopharmaceutical company discovering and developing innovative medicines to address unmet medical needs in immuno-oncology and autoimmune diseases. Leveraging its expertise in polymer chemistry and drug development, Nektar strives to create novel therapies that offer improved efficacy, safety, and patient convenience.
Serves as the central hub for research and development, administrative functions, and executive leadership.
Modern facilities equipped with advanced laboratories and collaboration spaces to foster innovation and scientific discovery.
Collaborative and dynamic environment fostering innovation, scientific excellence, and a patient-centric approach.
Represents Nektar's commitment to innovation and provides a strategic location for attracting top talent in the biotechnology sector.
While primarily focused on research and development within the United States, Nektar's clinical trials and partnerships extend its global reach, supporting research and development initiatives, clinical trial operations, and supply chain logistics.
455 Mission Bay Blvd South
San Francisco
California
USA
Address: 7901 US-72 W, Huntsville, AL 35806
Supports the manufacturing and supply chain operations, ensuring a reliable source of drug product.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Nektar Therapeutics' leadership includes:
Nektar Therapeutics has been backed by several prominent investors over the years, including:
Executive team has been stable in the last year, with no significant reported hires or exits. Future research would benefit from greater access to executive team announcements.
Discover the tools Nektar Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Nektar Therapeutics primarily uses the '[first_initial][last]@nektar.com' email format. Variations may exist.
[first_initial][last]@nektar.com
Format
jdoe@nektar.com
Example
75%
Success rate
Business Wire • 2024-01-08
Nektar Therapeutics (Nasdaq: NKTR) today announced that the Company’s compensation committee approved the grant of inducement awards to new employees under the Company’s 2018 Inducement Award Plan...more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Nektar Therapeutics, are just a search away.